The rapid advancement of biotechnology, personalized medicine, and next-generation therapeutics is driving significant growth in biologics CDMO services, regenerative medicine manufacturing, and cell therapy contract development. Pharmaceutical and biotechnology companies are increasingly outsourcing complex development and manufacturing activities to specialized contract...